Crimes and punishments; taking of crude oil or gasoline; making certain acts unlawful; effective date.
SB 833 is a bill that, as engrossed, would change Oklahoma law governing what medical expense evidence may be presented in personal injury lawsuits. It amends Title 12, Section 3009.1 to focus admissible medical damages on the amounts actually paid or the amounts necessary to satisfy the plaintiff’s financial obligation, rather than the amounts originally billed. The bill also allows certain provider statements or sworn testimony to be admitted to show that a lower amount will satisfy the debt, and it addresses how medical liens affect what amounts may still be shown to the jury.
The bill further creates a new Section 3009.2 to govern evidence of future medical treatment in personal injury cases. For future care not yet incurred, the admissible value would generally be the amount necessary to satisfy the expected financial obligation, with Medicare reimbursement rates used in specified circumstances, including when the plaintiff has no applicable coverage or when the applicable reimbursement rate cannot be determined. The bill applies these rules to personal injury actions filed on or after the effective date for future treatment evidence, while the amended Section 3009.1 applies to actions filed on or after November 1, 2015.
The bill’s impact is to narrow and standardize the evidence that can be used to prove medical damages in personal injury litigation, likely reducing the use of inflated billed charges and tying recoverable medical expense evidence more closely to actual payment obligations, insurance reimbursement, or Medicare-based rates. It would affect injured plaintiffs, defendants, medical providers, insurers, and trial courts by changing what documentation is admissible and how reasonable value is established for both past and future treatment.
The voting history suggests the measure had meaningful support but was not unanimous in the Senate. It passed the Senate Judiciary Committee 7-2 and later passed Senate third reading 29-18, indicating some division over the policy. The House third reading vote was unanimous at 89-0, suggesting broader agreement in the House on the final version of the bill.
The main point of contention appears to be the bill’s treatment of medical damages in personal injury cases, especially the use of Medicare reimbursement rates, insurance-based payment amounts, and lien-related limits instead of billed charges. Supporters likely viewed the bill as a reform to align damages evidence with actual economic loss and reduce inflated claims, while opponents may have been concerned that it could limit plaintiffs’ recovery or complicate proof of future medical costs and unpaid treatment obligations.
SB 833 would amend Title 12, Section 3009.1 and add new Section 3009.2 to Oklahoma’s civil procedure/evidence rules for personal injury cases. It changes admissible medical expense evidence from billed amounts to amounts actually paid or necessary to satisfy the obligation, allows provider acknowledgments or testimony to prove that amount, and uses Medicare reimbursement rates in certain unpaid or future-care situations. The bill would affect personal injury plaintiffs, defendants, health care providers, lienholders, insurers, and courts by changing how medical damages are proven and limited at trial.
The bill appears to have had generally favorable momentum, especially in the House, where it passed unanimously on third reading. In the Senate, it advanced through Judiciary Committee and passed third reading, but with a notable minority of opposition, indicating some concern about the policy’s effects. Overall, the sentiment suggests support for medical-damages reform, tempered by debate over how far the bill should go in limiting admissible medical billing evidence.
The central contention is whether personal injury damages should be based on billed charges or on amounts actually paid, payable, or reimbursable under insurance or Medicare. Supporters of the bill likely favor limiting evidence to actual financial obligations to prevent inflated medical specials, while critics may argue that the approach undervalues injuries, restricts recovery, or gives too much weight to Medicare rates and insurance arrangements. Additional friction may arise from the bill’s treatment of medical liens and its rules for future treatment, which can be harder to quantify and may affect plaintiffs without insurance differently from those with coverage.